OPTION CARE HEALTH, INC.

OPCH

CIK 0001014739 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$1.35B
↑+1.3% +$18Mvs FY2025 (Q1)
Operating Income
$73M
↓-8.4% -$7Mvs FY2025 (Q1)
Net Income
$45M
↓-3.0% -$1Mvs FY2025 (Q1)
Gross Profit
$262M
↓-0.4% -$1Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
49/100
  • Profitability
    25ROIC 9.9% (10% = solid, 20%+ = moat)
  • Liquidity
    51Current Ratio 1.53 (above 1.5 = solid)
  • Leverage
    56D/E 0.88 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 1.64x (1.0+ = capital-efficient)
  • Growth
    21Revenue YoY +1.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    40Op Margin 5.4% · trend -0.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project OPCH's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -2.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$18.56
Total enterprise IV
$3.03B
Diluted shares
0.16B
Terminal PV
$2.14B (70% of total)
Year-5 FCF
$252M
YearProjected FCFDiscounted PV
+1$224M$203M
+2$230M$190M
+3$237M$178M
+4$244M$167M
+5$252M$156M
Terminal$3.44B$2.14B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$41M
investment in PP&E
Stock buybacks (TTM)
$158M
share count reduction
Stock-based comp (TTM)
$41M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$3.38B
everything owned
Total liabilities
$2.03B
everything owed
Stockholders' equity
$1.35B
shareholder claim
Net debt
$982M
LT debt minus cash

Recent performance · 72 quarters

Revenue↑+1.3% +$18M
$1.35B
Net Income↓-3.0% -$1M
$45M
Free Cash Flow↓-27.6% -$5M
$-21M
Operating Margin↓-0.6pts
5.4%

Drill down